One of the micro-cap healthcare stocks engaged in the trading and supply of high-quality medical devices, surgical instruments, and pharmaceuticals, catering to hospitals, laboratories, and healthcare institutions. The stock has hit a 2 percent upper circuit after launching 11 new products of medical devices.
Stock Price Movement
With a market capitalization of Rs. 154.80 crores, the shares of Royal Sense Limited’s stock surged by 2 percent, reaching an upper circuit of Rs. 315.90 per share on Thursday, up from its previous closing price of Rs. 309.75 per share. Over the last years, the company has given a return of 157.37 percent.
What Happened
Royal Sense Limited is announcing the launch of 11 new ranges of medical devices, available for sale from January 6, 2024. The products include items such as nebulizers, breast pumps, walking sticks, crutches, toilet seats, and more.
The products are designed to address various healthcare needs and will be marketed primarily in the domestic market. This launch reflects the company’s commitment to providing high-quality innovative solutions to enhance the well-being and comfort of individuals.
Products Offering
Royal Sense Limited offers a wide range of products, including medical equipment, surgical instruments, consumables, laboratory reagents, and diagnostic kits. Committed to quality, the company ensures adherence to strict standards while driving innovation through ongoing research and development.
IPO Details
Royal Sense Limited is set to launch its Initial Public Offering (IPO) from March 12 to March 14, 2024. The IPO aims to raise approximately Rs. 9.86 crores by offering 14.50 lakh equity shares at an issue price of Rs. 68 per share. This initiative is part of the company’s strategy to fund its working capital requirements and support general corporate purposes.
Also read…
Recent quarter results and ratios
Royal Sense Limited’s revenue has increased from Rs. 17.80 crore in H2 FY24 to Rs. 22.02 crore in H1 FY25, which has grown by 23.71 percent. The net profit of Royal Sense Limited has also grown by 49.69 percent from Rs. 1.59 crore in Q2 FY24 to Rs. 2.38 crore in Q2 FY25.
In terms of return ratios, the company’s ROCE and ROE should be 19.26 percent and 24.73 percent, respectively. The debt-to-equity ratio of the company is to be 0.08x, which shows the company is almost debt-free. Royal Sense Limited’s EPS is to be Rs. 2.97.
Shareholding pattern
In September 2024, Royal Sense Limited had a majority stake held by the promoters at 67.96 percent and the public at 32.05 percent.
Company Overview
Royal Sense Limited was founded in April 2023 and is headquartered in Mumbai, India. The company specializes in medical equipment, surgical instruments, consumables, laboratory reagents, medical disposables, and diagnostic kits.
The company aims to enhance healthcare outcomes by providing advanced solutions to meet the evolving needs of healthcare professionals and patients worldwide.
Written by – Nikhil Naik
Disclaimer
The views and investment tips expressed by investment experts/broking houses/rating agencies on tradebrains.in are their own, and not that of the website or its management. Investing in equities poses a risk of financial losses. Investors must therefore exercise due caution while investing or trading in stocks. Dailyraven Technologies or the author are not liable for any losses caused as a result of the decision based on this article. Please consult your investment advisor before investing.
Start Your Stock Market Journey Today!
Want to learn Stock Market trading and Investing? Make sure to check out exclusive Stock Market courses by FinGrad, the learning initiative by Trade Brains. You can enroll in FREE courses and webinars available on FinGrad today and get ahead in your trading career. Join now!!
